Core Laboratories NV (CLB)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | ||
|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 126,111 | 139,872 | 147,621 | 160,370 |
| Total stockholders’ equity | US$ in thousands | 251,991 | 250,742 | 240,274 | 232,155 |
| Debt-to-equity ratio | 0.50 | 0.56 | 0.61 | 0.69 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $126,111K ÷ $251,991K
= 0.50
The debt-to-equity ratio of Core Laboratories NV has shown a decreasing trend over the four quarters provided. Starting at 0.69 in March 31, 2024, the ratio decreased to 0.61 by June 30, 2024, and further decreased to 0.56 by September 30, 2024, and finally to 0.50 by December 31, 2024. This indicates that the company has been reducing its reliance on debt financing in relation to equity, which can be seen as a positive sign of financial stability and potentially lower financial risk. However, further analysis is needed to understand the reasons behind this trend and to assess its implications for the company's overall financial health and strategic direction.
Peer comparison
Dec 31, 2024